| P50 | author | Werner Poewe | Q28359617 |
| P2093 | author name string | Wenning GK | |
| | Ransmayr G | |
| | Boesch SM | |
| P2860 | cites work | The dopaminergic response in multiple system atrophy | Q28317869 |
| | The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease | Q28373127 |
| | Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings? | Q31932072 |
| | What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? | Q33180015 |
| | Consensus statement on the diagnosis of multiple system atrophy. | Q33605440 |
| | Multiple system atrophy--the nature of the beast | Q33631707 |
| | Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT | Q33733062 |
| | Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms | Q36318977 |
| | Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. | Q36722978 |
| | Multiple system atrophy: a review of 203 pathologically proven cases | Q36852143 |
| | Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria | Q36879516 |
| | Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy | Q37967188 |
| | Dystonia in Parkinson's disease: clinical and pharmacological features | Q42213318 |
| | Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality | Q44667840 |
| | A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa | Q45087241 |
| | Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia | Q48113790 |
| | Single-unit activity of cerebellar nuclear cells in the awake genetically dystonic rat. | Q48309806 |
| | The natural history of Parkinson's disease | Q48389488 |
| | Functional brain networks in movement disorders | Q48402138 |
| | The pathophysiology of primary dystonia | Q48423358 |
| | Cerebral and cerebellar activation in correlation to the action-induced dystonia in writer's cramp. | Q48456828 |
| | The neurophysiology of dystonia | Q48459680 |
| | Idiopathic orthostatic hypotension. Biochemical and pathologic observations in 2 cases | Q48492060 |
| | Striatonigral degeneration. A clinicopathological study | Q48842299 |
| | Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study | Q49099655 |
| | The behavioural and motor consequences of focal lesions of the basal ganglia in man. | Q51132485 |
| | Survival in multiple system atrophy: a study of prognostic factors in 59 cases. | Q52888623 |
| | Bupropion in Parkinson's disease. | Q55062563 |
| | Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study | Q64768953 |
| | Striato-nigral degeneration. Apropos of a clinical, therapeutic, and anatomic study of 2 cases | Q64864800 |
| | Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia | Q67217660 |
| | Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology | Q69771937 |
| | [Striatonigral degeneration associated with olivopontocerebellar atrophy. Anatomo-clinical study of 3 cases. Nosologic discussion] | Q70442928 |
| | “Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical study | Q72000166 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 300-303 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Dystonia in multiple system atrophy. | |
| P478 | volume | 72 | |